M Holdings Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.67M | Buy |
47,562
+3,100
| +7% | +$181K | 0.18% | 104 |
|
|
2025
Q4 | $2.4M | Buy |
+44,462
| New | +$2.14M | 0.17% | 106 |
|
|
2025
Q2 | – | Sell |
-11,622
| Closed | -$709K | – | 160 |
|
|
2025
Q1 | $709K | Sell |
11,622
-580
| -5% | -$33.8K | 0.12% | 113 |
|
|
2024
Q4 | $690K | Buy |
+12,202
| New | +$682K | 0.11% | 104 |
|
|
2024
Q2 | – | Sell |
-14,351
| Closed | -$778K | – | 312 |
|
|
2024
Q1 | $778K | Sell |
14,351
-2,055
| -13% | -$105K | 0.13% | 94 |
|
|
2023
Q4 | $842K | Buy |
16,406
+377
| +2% | +$19.8K | 0.1% | 125 |
|
|
2023
Q3 | $930K | Buy |
+16,029
| New | +$982K | 0.12% | 118 |
|
|
2023
Q1 | – | Sell |
-16,349
| Closed | -$1.15M | – | 480 |
|
|
2022
Q4 | $1.18M | Buy |
16,349
+175
| +1% | +$13.2K | 0.12% | 140 |
|
|
2022
Q3 | $1.15M | Sell |
16,174
-167
| -1% | -$12.1K | 0.13% | 137 |
|
|
2022
Q2 | $1.26M | Sell |
16,341
-5,099
| -24% | -$388K | 0.13% | 134 |
|
|
2022
Q1 | $1.57M | Buy |
+21,440
| New | +$1.44M | 0.12% | 138 |
|
|
2021
Q2 | $1.32M | Sell |
19,690
-621
| -3% | -$40.5K | 0.13% | 131 |
|
|
2021
Q1 | $1.28M | Sell |
20,311
-3,344
| -14% | -$208K | 0.12% | 164 |
|
|
2020
Q4 | $1.47M | Buy |
23,655
+3,742
| +19% | +$230K | 0.19% | 103 |
|
|
2020
Q3 | $1.2M | Sell |
19,913
-480
| -2% | -$28.9K | 0.19% | 101 |
|
|
2020
Q2 | $1.2M | Sell |
20,393
-9,769
| -32% | -$584K | 0.21% | 98 |
|
|
2020
Q1 | $1.68M | Buy |
30,162
+4,469
| +17% | +$273K | 0.25% | 103 |
|
|
2019
Q4 | $1.65M | Buy |
25,693
+1,751
| +7% | +$100K | 0.48% | 61 |
|
|
2019
Q3 | $1.21M | Buy |
23,942
+5,091
| +27% | +$239K | 0.37% | 78 |
|
|
2019
Q2 | $855K | Sell |
18,851
-13,030
| -41% | -$607K | 0.29% | 90 |
|
|
2019
Q1 | $1.52M | Buy |
31,881
+17,554
| +123% | +$874K | 0.35% | 75 |
|
|
2018
Q4 | $745K | Buy |
14,327
+290
| +2% | +$15.6K | 0.23% | 118 |
|
|
2018
Q3 | $871K | Sell |
14,037
-18,620
| -57% | -$1.1M | 0.23% | 115 |
|
|
2018
Q2 | $1.81M | Buy |
32,657
+1,895
| +6% | +$102K | 0.5% | 49 |
|
|
2018
Q1 | $1.95M | Sell |
30,762
-4,339
| -12% | -$279K | 0.59% | 38 |
|
|
2017
Q4 | $2.15M | Buy |
35,101
+990
| +3% | +$61.9K | 0.65% | 35 |
|
|
2017
Q3 | $2.17M | Buy |
34,111
+14,877
| +77% | +$869K | 0.69% | 30 |
|
|
2017
Q2 | $1.07M | Buy |
19,234
+2,719
| +16% | +$148K | 0.37% | 78 |
|
|
2017
Q1 | $898K | Buy |
16,515
+1,029
| +7% | +$56.4K | 0.35% | 83 |
|
|
2016
Q4 | $905K | Buy |
15,486
+813
| +6% | +$44.4K | 0.31% | 83 |
|
|
2016
Q3 | $791K | Buy |
14,673
+7,272
| +98% | +$467K | 0.36% | 79 |
|
|
2016
Q2 | $544K | Buy |
7,401
+1,992
| +37% | +$141K | 0.28% | 110 |
|
|
2016
Q1 | $346K | Buy |
5,409
+104
| +2% | +$6.56K | 0.21% | 137 |
|
|
2015
Q4 | $365K | Sell |
5,305
-94
| -2% | -$6.21K | 0.24% | 125 |
|
|
2015
Q3 | $320K | Buy |
5,399
+1,204
| +29% | +$76.4K | 0.23% | 130 |
|
|
2015
Q2 | $279K | Sell |
4,195
-29
| -0.7% | -$1.91K | 0.19% | 141 |
|
|
2015
Q1 | $272K | Buy |
4,224
+5
| +0.1% | +$313 | 0.18% | 145 |
|
|
2014
Q4 | $249K | Sell |
4,219
-1,396
| -25% | -$78.7K | 0.16% | 144 |
|
|
2014
Q3 | $285K | Buy |
5,615
+1,069
| +24% | +$53.4K | 0.16% | 144 |
|
|
2014
Q2 | $221K | Buy |
+4,546
| New | +$224K | 0.14% | 167 |
|
|
2014
Q1 | – | Sell |
-4,185
| Closed | -$222K | – | 157 |
|
|
2013
Q4 | $222K | Buy |
+4,185
| New | +$213K | 0.16% | 145 |
|
Other funds holding BMY
VCM
VPM
M Holdings Securities's BMY Position: Q1 2026 in Review
M Holdings Securities increased its Bristol-Myers Squibb (BMY) stake by 7% in Q1 2026, buying an estimated $181K and bringing the position to 47,562 shares worth $2.67M. The position accounts for 0.18% of the portfolio, ranked #104.
M Holdings Securities first reported a position in BMY in Q4 2013 and has held it in 41 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- M Holdings Securities held 47,562 shares of Bristol-Myers Squibb worth $2.67M as of Q1 2026.
- M Holdings Securities bought 3,100 Bristol-Myers Squibb shares in Q1 2026, an estimated $181K.
- Bristol-Myers Squibb made up 0.18% of M Holdings Securities's portfolio in Q1 2026, its #104 holding.
- M Holdings Securities first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 41 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on M Holdings Securities's 13F filing for Q1 2026, filed 12 May 2026.